IP Library Granted Patent US 7,271,248
Granted Patent B2
US 7,271,248 · App. 10/975,909 · Granted Sep 18, 2007

Human receptor proteins; related reagents and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,271,248
App. No.
10/975,909
Granted
Sep 18, 2007
Kind
B2
Abstract

Nucleic acids encoding mammalian Toll-like receptors (TLRs) have been identified in human cells. Recombinantly produced TLRs are used in the preparation of antibodies that are capable of binding to the TLRs. The antibodies are advantageously used in the prevention and treatment of septic shock, inflammatory conditions, and viral infections.

Claims (12)

1. An isolated antibody or fragment thereof that specifically binds to an isolated or recombinant polypeptide comprising the amino acid sequence of SEQ ID NO: 8.

2. The antibody or fragment thereof of claim 1 , wherein said antibody or fragment thereof further comprises a detectable label or purification tag.

3. The antibody or fragment thereof of claim 1 , wherein said antibody or fragment thereof is attached to a solid support.

4. The antibody of claim 1 , wherein said antibody is a monoclonal antibody.

5. The antibody of claim 4 , wherein said antibody is a chimeric antibody.

6. The antibody of claim 4 , wherein said antibody is a humanized antibody.

7. The fragment claim 1 , wherein said fragment is an Fv, Fab, Fab′, F(ab′) 2 , or single-chain Fv.

8. The antibody of claim 1 , wherein said antibody is an antagonist antibody.

9. A hybridoma that produces the antibody of claim 1 .

10. The antibody or fragment thereof of claim 1 , wherein said antibody is a recombinant immunoglobulin.

11. A composition comprising the antibody or fragment thereof of claim 1 .

12. A composition comprising the antibody or fragment thereof of claim 1 and a pharmaceutically acceptable carrier.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →